Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Jardiance

empagliflozin

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  TAB: 10 mg, 25 mg

diabetes mellitus, type 2

[10-25 mg PO qam]
Start: 10 mg PO qam; Info: hold tx at least 3 days before surgery/procedure if prolonged fasting

cardiovascular event risk reduction - DM type 2 patients with established cardiovascular disease

[10 mg PO qam]
Info: may incr. dose to 25 mg PO qam if additional glycemic control needed; hold tx at least 3 days before surgery/procedure if prolonged fasting

heart failure-associated risk reduction - heart failure patients

[10 mg PO qam]
Info: hold tx at least 3 days before surgery/procedure if prolonged fasting

kidney disease progression and cardiovascular-associated risk reduction - CKD patients with progression risk

[10 mg PO qam]
Info: hold tx at least 3 days before surgery/procedure if prolonged fasting

renal dosing

[diabetes mellitus, type 2]
eGFR <30: avoid use for glycemic control
HD/PD: not defined
[all other indications]
eGFR >20: no adjustment; eGFR <20: not defined; Info: if eGFR <20 during tx, may continue 10 mg/day for cardiovascular or kidney benefit
HD/PD: not defined

hepatic dosing

[no adjustment]

Peds Dosing .

Dosage forms:  TAB: 10 mg, 25 mg

diabetes mellitus, type 2

[10 yo and older]
Dose: 10-25 mg PO qam; Start: 10 mg PO qam; Info: hold tx at least 3 days before surgery/procedure if prolonged fasting

renal dosing

[see below]
renal impairment: not defined, consider adult renal dosing for guidance
HD/PD: not defined

hepatic dosing

[no adjustment]

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@6c2af77c
  • hypersensitivity to drug or ingredient
  • pregnancy 2nd trimester
  • pregnancy 3rd trimester
  • breastfeeding
  • diabetic ketoacidosis
  • volume depletion
  • eGFR <30 (diabetes mellitus tx use)
  • caution: pregnancy 1st trimester
  • caution: eGFR <60
  • caution: hypotension
  • caution: elderly patients
  • caution: ketoacidosis risk
  • caution: pancreatic disorder
  • caution: fasting
  • caution: febrile illness, acute
  • caution: surgery
  • caution: ketogenic diet
  • caution: alcohol abuse
  • caution: hyperlipidemia
  • caution: GU infection history, recurrent
  • caution: GU infection history, chronic
  • caution: uncircumcised penis
  • caution: diabetic foot ulcer
  • caution: PVD
  • caution: amputation history

Drug Interactions .

Overview

empagliflozin

SGLT2 inhibitor

Interaction Characteristics:
  • antidiabetic agent
  • fluid/electrolyte loss
  • hypotensive effects

Avoid/Use Alternative

  • aldesleukin
  • Jardiance (empagliflozin)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    empagliflozin + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • bexagliflozin
  • Jardiance (empagliflozin)
    +
    bexagliflozin
    1 interaction

    Avoid/Use Alternative

    empagliflozin + bexagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • canagliflozin
  • Jardiance (empagliflozin)
    +
    canagliflozin
    1 interaction

    Avoid/Use Alternative

    empagliflozin + canagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • dapagliflozin
  • Jardiance (empagliflozin)
    +
    dapagliflozin
    1 interaction

    Avoid/Use Alternative

    empagliflozin + dapagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • empagliflozin
  • Jardiance (empagliflozin)
    +
    empagliflozin
    1 interaction

    Avoid/Use Alternative

    empagliflozin + empagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • ertugliflozin
  • Jardiance (empagliflozin)
    +
    ertugliflozin
    1 interaction

    Avoid/Use Alternative

    empagliflozin + ertugliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • lofexidine
  • Jardiance (empagliflozin)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    empagliflozin + lofexidine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sotagliflozin
  • Jardiance (empagliflozin)
    +
    sotagliflozin
    1 interaction

    Avoid/Use Alternative

    empagliflozin + sotagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

  • acebutolol
  • Jardiance (empagliflozin)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + acebutolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • alclometasone topical
  • Jardiance (empagliflozin)
    +
    alclometasone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + alclometasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alfentanil
  • Jardiance (empagliflozin)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + alfentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Jardiance (empagliflozin)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Jardiance (empagliflozin)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    empagliflozin + aliskiren

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • alpelisib
  • Jardiance (empagliflozin)
    +
    alpelisib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + alpelisib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprostadil intracavernous
  • Jardiance (empagliflozin)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    empagliflozin + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension, including orthostasis (additive effects)

  • amantadine
  • Jardiance (empagliflozin)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amcinonide topical
  • Jardiance (empagliflozin)
    +
    amcinonide topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + amcinonide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • amifostine
  • Jardiance (empagliflozin)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • amiloride
  • Jardiance (empagliflozin)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    empagliflozin + amiloride

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amitriptyline
  • Jardiance (empagliflozin)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    empagliflozin + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amlodipine
  • Jardiance (empagliflozin)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + amlodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amoxapine
  • Jardiance (empagliflozin)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • apomorphine
  • Jardiance (empagliflozin)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Jardiance (empagliflozin)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    empagliflozin + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aprocitentan
  • Jardiance (empagliflozin)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    empagliflozin + aprocitentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole bimonthly injection
  • Jardiance (empagliflozin)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    empagliflozin + aripiprazole bimonthly injection

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • aripiprazole lauroxil
  • Jardiance (empagliflozin)
    +
    aripiprazole lauroxil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + aripiprazole lauroxil

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • aripiprazole monthly injection
  • Jardiance (empagliflozin)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    empagliflozin + aripiprazole monthly injection

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • aripiprazole oral
  • Jardiance (empagliflozin)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    empagliflozin + aripiprazole oral

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • arsenic trioxide
  • Jardiance (empagliflozin)
    +
    arsenic trioxide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + arsenic trioxide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • articaine
  • Jardiance (empagliflozin)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + articaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • asenapine
  • Jardiance (empagliflozin)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + asenapine

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • asparaginase
  • Jardiance (empagliflozin)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    empagliflozin + asparaginase

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • atazanavir
  • Jardiance (empagliflozin)
    +
    atazanavir
    1 interaction

    Monitor/Modify Tx

    empagliflozin + atazanavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • atenolol
  • Jardiance (empagliflozin)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + atenolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • avanafil
  • Jardiance (empagliflozin)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Jardiance (empagliflozin)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + azilsartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • benazepril
  • Jardiance (empagliflozin)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + benazepril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • berberine
  • Jardiance (empagliflozin)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + berberine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betamethasone
  • Jardiance (empagliflozin)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + betamethasone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • betamethasone topical
  • Jardiance (empagliflozin)
    +
    betamethasone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + betamethasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • betaxolol
  • Jardiance (empagliflozin)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + betaxolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol ophthalmic
  • Jardiance (empagliflozin)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    empagliflozin + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bethanechol
  • Jardiance (empagliflozin)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + bethanechol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bisoprolol
  • Jardiance (empagliflozin)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + bisoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bortezomib
  • Jardiance (empagliflozin)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + bortezomib

    monitor BP, glucose: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • brentuximab vedotin
  • Jardiance (empagliflozin)
    +
    brentuximab vedotin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + brentuximab vedotin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • brexpiprazole
  • Jardiance (empagliflozin)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    empagliflozin + brexpiprazole

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • brigatinib
  • Jardiance (empagliflozin)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + brigatinib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • brimonidine ophthalmic
  • Jardiance (empagliflozin)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    empagliflozin + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • brimonidine topical
  • Jardiance (empagliflozin)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Jardiance (empagliflozin)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + bromocriptine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • budesonide
  • Jardiance (empagliflozin)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + budesonide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • bumetanide
  • Jardiance (empagliflozin)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + bumetanide

    monitor glucose, electrolytes, volume status, renal fxn, BP: combo may incr. risk of electrolyte abnormalities, dehydration, hypovolemia, renal impairment, hypotension (including orthostasis), other adverse effects; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bupivacaine
  • Jardiance (empagliflozin)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + bupivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bupivacaine liposomal
  • Jardiance (empagliflozin)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    empagliflozin + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • buprenorphine
  • Jardiance (empagliflozin)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • butorphanol
  • Jardiance (empagliflozin)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + butorphanol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cabergoline
  • Jardiance (empagliflozin)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    empagliflozin + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • calaspargase
  • Jardiance (empagliflozin)
    +
    calaspargase
    1 interaction

    Monitor/Modify Tx

    empagliflozin + calaspargase

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • candesartan cilexetil
  • Jardiance (empagliflozin)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + candesartan cilexetil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cannabis
  • Jardiance (empagliflozin)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    empagliflozin + cannabis

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • capivasertib
  • Jardiance (empagliflozin)
    +
    capivasertib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + capivasertib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • captopril
  • Jardiance (empagliflozin)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + captopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cariprazine
  • Jardiance (empagliflozin)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + cariprazine

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • carteolol ophthalmic
  • Jardiance (empagliflozin)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    empagliflozin + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • carvedilol
  • Jardiance (empagliflozin)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + carvedilol

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis (antagonistic effects; additive effects)

  • ceritinib
  • Jardiance (empagliflozin)
    +
    ceritinib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ceritinib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • chloroprocaine
  • Jardiance (empagliflozin)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + chloroprocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlorothiazide
  • Jardiance (empagliflozin)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + chlorothiazide

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • chlorpromazine
  • Jardiance (empagliflozin)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Jardiance (empagliflozin)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + chlorthalidone

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • cilostazol
  • Jardiance (empagliflozin)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + cilostazol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ciprofloxacin
  • Jardiance (empagliflozin)
    +
    ciprofloxacin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ciprofloxacin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects, fluoroquinolones may alter blood glucose)

  • clevidipine
  • Jardiance (empagliflozin)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + clevidipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clobetasol topical
  • Jardiance (empagliflozin)
    +
    clobetasol topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + clobetasol topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • clocortolone topical
  • Jardiance (empagliflozin)
    +
    clocortolone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + clocortolone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • clofarabine
  • Jardiance (empagliflozin)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + clofarabine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • clomipramine
  • Jardiance (empagliflozin)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + clomipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clonidine
  • Jardiance (empagliflozin)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + clonidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clozapine
  • Jardiance (empagliflozin)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + clozapine

    monitor glucose, BP, HR: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • codeine
  • Jardiance (empagliflozin)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + codeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • coenzyme Q-10
  • Jardiance (empagliflozin)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    empagliflozin + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • copanlisib
  • Jardiance (empagliflozin)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + copanlisib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects, copanlisib may cause infusion-related hyperglycemia)

  • corticotropin
  • Jardiance (empagliflozin)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + corticotropin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • cortisone
  • Jardiance (empagliflozin)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + cortisone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dabrafenib
  • Jardiance (empagliflozin)
    +
    dabrafenib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dabrafenib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • danazol
  • Jardiance (empagliflozin)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + danazol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • darunavir
  • Jardiance (empagliflozin)
    +
    darunavir
    1 interaction

    Monitor/Modify Tx

    empagliflozin + darunavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • decitabine
  • Jardiance (empagliflozin)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + decitabine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • deflazacort
  • Jardiance (empagliflozin)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    empagliflozin + deflazacort

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • delafloxacin
  • Jardiance (empagliflozin)
    +
    delafloxacin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + delafloxacin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects, fluoroquinolones may alter blood glucose)

  • denileukin diftitox
  • Jardiance (empagliflozin)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    empagliflozin + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Jardiance (empagliflozin)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    empagliflozin + desflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desipramine
  • Jardiance (empagliflozin)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + desipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desogestrel (contraceptive)
  • Jardiance (empagliflozin)
    +
    desogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + desogestrel (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • desonide topical
  • Jardiance (empagliflozin)
    +
    desonide topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + desonide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • desoximetasone topical
  • Jardiance (empagliflozin)
    +
    desoximetasone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + desoximetasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dexamethasone
  • Jardiance (empagliflozin)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dexamethasone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dexmedetomidine
  • Jardiance (empagliflozin)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dexmedetomidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Jardiance (empagliflozin)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dexmedetomidine injection

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • diazoxide
  • Jardiance (empagliflozin)
    +
    diazoxide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + diazoxide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dienogest (contraceptive)
  • Jardiance (empagliflozin)
    +
    dienogest (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dienogest (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • diflorasone topical
  • Jardiance (empagliflozin)
    +
    diflorasone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + diflorasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dihydrocodeine
  • Jardiance (empagliflozin)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • diltiazem
  • Jardiance (empagliflozin)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    empagliflozin + diltiazem

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dinutuximab
  • Jardiance (empagliflozin)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • dipyridamole
  • Jardiance (empagliflozin)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • doxazosin
  • Jardiance (empagliflozin)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Jardiance (empagliflozin)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dronabinol
  • Jardiance (empagliflozin)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + dronabinol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • drospirenone (contraceptive)
  • Jardiance (empagliflozin)
    +
    drospirenone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + drospirenone (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Jardiance (empagliflozin)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + duloxetine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enalapril
  • Jardiance (empagliflozin)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + enalapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enalaprilat
  • Jardiance (empagliflozin)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    empagliflozin + enalaprilat

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enfortumab vedotin
  • Jardiance (empagliflozin)
    +
    enfortumab vedotin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + enfortumab vedotin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ensartinib
  • Jardiance (empagliflozin)
    +
    ensartinib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ensartinib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • entacapone
  • Jardiance (empagliflozin)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Jardiance (empagliflozin)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + entrectinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ephedra
  • Jardiance (empagliflozin)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ephedra

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • epinephrine
  • Jardiance (empagliflozin)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + epinephrine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • eplerenone
  • Jardiance (empagliflozin)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + eplerenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • epoprostenol
  • Jardiance (empagliflozin)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • esmolol
  • Jardiance (empagliflozin)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + esmolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • estetrol (contraceptive)
  • Jardiance (empagliflozin)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + estetrol (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • estradiol (contraceptive)
  • Jardiance (empagliflozin)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + estradiol (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • estradiol (hormone replacement)
  • Jardiance (empagliflozin)
    +
    estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + estradiol (hormone replacement)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • estrogens, conjugated (hormone replacement)
  • Jardiance (empagliflozin)
    +
    estrogens, conjugated (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + estrogens, conjugated (hormone replacement)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • estrogens, esterified (hormone replacement)
  • Jardiance (empagliflozin)
    +
    estrogens, esterified (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + estrogens, esterified (hormone replacement)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ethacrynic acid
  • Jardiance (empagliflozin)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ethacrynic acid

    monitor BP, glucose, volume status, renal fxn: combo may incr. risk of hypovolemia, renal impairment, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • ethanol (alcoholic beverage)
  • Jardiance (empagliflozin)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ethanol injection
  • Jardiance (empagliflozin)
    +
    ethanol injection
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ethinyl estradiol (contraceptive)
  • Jardiance (empagliflozin)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ethinyl estradiol (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ethinyl estradiol (hormone replacement)
  • Jardiance (empagliflozin)
    +
    ethinyl estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ethinyl estradiol (hormone replacement)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ethynodiol (contraceptive)
  • Jardiance (empagliflozin)
    +
    ethynodiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ethynodiol (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • etonogestrel (contraceptive)
  • Jardiance (empagliflozin)
    +
    etonogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + etonogestrel (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • etripamil nasal
  • Jardiance (empagliflozin)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    empagliflozin + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • everolimus
  • Jardiance (empagliflozin)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    empagliflozin + everolimus

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • felodipine
  • Jardiance (empagliflozin)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + felodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fenoldopam
  • Jardiance (empagliflozin)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fenoldopam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fentanyl
  • Jardiance (empagliflozin)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fentanyl

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Jardiance (empagliflozin)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ferumoxytol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flaxseed
  • Jardiance (empagliflozin)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    empagliflozin + flaxseed

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flibanserin
  • Jardiance (empagliflozin)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • fludrocortisone
  • Jardiance (empagliflozin)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fludrocortisone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluocinolone otic
  • Jardiance (empagliflozin)
    +
    fluocinolone otic
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fluocinolone otic

    monitor glucose w/ prolonged otic corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluocinolone topical
  • Jardiance (empagliflozin)
    +
    fluocinolone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fluocinolone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluocinonide topical
  • Jardiance (empagliflozin)
    +
    fluocinonide topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fluocinonide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluphenazine
  • Jardiance (empagliflozin)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flurandrenolide topical
  • Jardiance (empagliflozin)
    +
    flurandrenolide topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + flurandrenolide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluticasone propionate topical
  • Jardiance (empagliflozin)
    +
    fluticasone propionate topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fluticasone propionate topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fosamprenavir
  • Jardiance (empagliflozin)
    +
    fosamprenavir
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fosamprenavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fosinopril
  • Jardiance (empagliflozin)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fosinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • foslevodopa
  • Jardiance (empagliflozin)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    empagliflozin + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fosphenytoin
  • Jardiance (empagliflozin)
    +
    fosphenytoin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + fosphenytoin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • furosemide
  • Jardiance (empagliflozin)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + furosemide

    monitor BP, glucose, volume status, renal fxn: combo may incr. risk of hypovolemia, renal impairment, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • garlic
  • Jardiance (empagliflozin)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    empagliflozin + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • gilteritinib
  • Jardiance (empagliflozin)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + gilteritinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ginkgo
  • Jardiance (empagliflozin)
    +
    ginkgo
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ginkgo

    monitor glucose: combo may alter glycemic control (mechanism unknown, ginkgo may have various effects on glucose metabolism)

  • glimepiride
  • Jardiance (empagliflozin)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    empagliflozin + glimepiride

    monitor glucose; consider decr. glimepiride dose: combo may incr. risk of hypoglycemia (additive effects)

  • glipizide
  • Jardiance (empagliflozin)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + glipizide

    monitor glucose; consider decr. glipizide dose: combo may incr. risk of hypoglycemia (additive effects)

  • glyburide
  • Jardiance (empagliflozin)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + glyburide

    monitor glucose; consider decr. glyburide dose: combo may incr. risk of hypoglycemia (additive effects)

  • goserelin
  • Jardiance (empagliflozin)
    +
    goserelin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + goserelin

    monitor glucose if prostate cancer use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • guanfacine
  • Jardiance (empagliflozin)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + guanfacine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • halcinonide topical
  • Jardiance (empagliflozin)
    +
    halcinonide topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + halcinonide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • halobetasol topical
  • Jardiance (empagliflozin)
    +
    halobetasol topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + halobetasol topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • haloperidol
  • Jardiance (empagliflozin)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydralazine
  • Jardiance (empagliflozin)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + hydralazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydrochlorothiazide
  • Jardiance (empagliflozin)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + hydrochlorothiazide

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • hydrocodone
  • Jardiance (empagliflozin)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydrocortisone
  • Jardiance (empagliflozin)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + hydrocortisone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • hydrocortisone topical
  • Jardiance (empagliflozin)
    +
    hydrocortisone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + hydrocortisone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • hydromorphone
  • Jardiance (empagliflozin)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • iloperidone
  • Jardiance (empagliflozin)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + iloperidone

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • iloprost
  • Jardiance (empagliflozin)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    empagliflozin + iloprost

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Jardiance (empagliflozin)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • inavolisib
  • Jardiance (empagliflozin)
    +
    inavolisib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + inavolisib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • indapamide
  • Jardiance (empagliflozin)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + indapamide

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • insulin
  • Jardiance (empagliflozin)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + insulin

    monitor glucose; consider dose adjustment of one or both drugs: combo may incr. risk of hypoglycemia (additive effects)

  • irbesartan
  • Jardiance (empagliflozin)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    empagliflozin + irbesartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • iron sucrose
  • Jardiance (empagliflozin)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    empagliflozin + iron sucrose

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isocarboxazid
  • Jardiance (empagliflozin)
    +
    isocarboxazid
    1 interaction

    Monitor/Modify Tx

    empagliflozin + isocarboxazid

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isoflurane
  • Jardiance (empagliflozin)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    empagliflozin + isoflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isoniazid
  • Jardiance (empagliflozin)
    +
    isoniazid
    1 interaction

    Monitor/Modify Tx

    empagliflozin + isoniazid

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • isosorbide dinitrate
  • Jardiance (empagliflozin)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    empagliflozin + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isosorbide mononitrate
  • Jardiance (empagliflozin)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    empagliflozin + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isradipine
  • Jardiance (empagliflozin)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + isradipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • labetalol
  • Jardiance (empagliflozin)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + labetalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • landiolol
  • Jardiance (empagliflozin)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + landiolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lanreotide
  • Jardiance (empagliflozin)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lanreotide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • leuprolide
  • Jardiance (empagliflozin)
    +
    leuprolide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + leuprolide

    monitor glucose if prostate cancer use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • levobunolol ophthalmic
  • Jardiance (empagliflozin)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    empagliflozin + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • levodopa
  • Jardiance (empagliflozin)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    empagliflozin + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levofloxacin
  • Jardiance (empagliflozin)
    +
    levofloxacin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + levofloxacin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects, fluoroquinolones may alter blood glucose)

  • levonorgestrel (contraceptive)
  • Jardiance (empagliflozin)
    +
    levonorgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + levonorgestrel (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • levorphanol
  • Jardiance (empagliflozin)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • levothyroxine
  • Jardiance (empagliflozin)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + levothyroxine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lidocaine
  • Jardiance (empagliflozin)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lidocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • liothyronine
  • Jardiance (empagliflozin)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + liothyronine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisinopril
  • Jardiance (empagliflozin)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lisinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lithium
  • Jardiance (empagliflozin)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lithium

    monitor lithium levels: combo may incr. or decr. lithium levels, incr. risk of adverse effects or decr. efficacy (lithium renal excretion possibly altered)

  • lopinavir/ritonavir
  • Jardiance (empagliflozin)
    +
    lopinavir/ ritonavir
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lopinavir/ ritonavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lorlatinib
  • Jardiance (empagliflozin)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lorlatinib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • losartan
  • Jardiance (empagliflozin)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    empagliflozin + losartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • loxapine
  • Jardiance (empagliflozin)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Jardiance (empagliflozin)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lumateperone
  • Jardiance (empagliflozin)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lumateperone

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • lurasidone
  • Jardiance (empagliflozin)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lurasidone

    monitor BP, glucose; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • lutetium Lu 177 dotatate
  • Jardiance (empagliflozin)
    +
    lutetium Lu 177 dotatate
    1 interaction

    Monitor/Modify Tx

    empagliflozin + lutetium Lu 177 dotatate

    monitor glucose: combo may decr. empagliflozin efficacy (antagonistic effects)

  • magnesium sulfate
  • Jardiance (empagliflozin)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    empagliflozin + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • maraviroc
  • Jardiance (empagliflozin)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    empagliflozin + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • medroxyprogesterone (contraceptive)
  • Jardiance (empagliflozin)
    +
    medroxyprogesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + medroxyprogesterone (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • megestrol
  • Jardiance (empagliflozin)
    +
    megestrol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + megestrol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • meperidine
  • Jardiance (empagliflozin)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Jardiance (empagliflozin)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + mepivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methadone
  • Jardiance (empagliflozin)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • methohexital
  • Jardiance (empagliflozin)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    empagliflozin + methohexital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methyldopa
  • Jardiance (empagliflozin)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    empagliflozin + methyldopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylene blue injection
  • Jardiance (empagliflozin)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    empagliflozin + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylprednisolone
  • Jardiance (empagliflozin)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + methylprednisolone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • metolazone
  • Jardiance (empagliflozin)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + metolazone

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • metoprolol
  • Jardiance (empagliflozin)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + metoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • midazolam
  • Jardiance (empagliflozin)
    +
    midazolam
    1 interaction

    Monitor/Modify Tx

    empagliflozin + midazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • milrinone
  • Jardiance (empagliflozin)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + milrinone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • milsaperidone
  • Jardiance (empagliflozin)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + milsaperidone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • minoxidil
  • Jardiance (empagliflozin)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + minoxidil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mirtazapine
  • Jardiance (empagliflozin)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + mirtazapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • moexipril
  • Jardiance (empagliflozin)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + moexipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • molindone
  • Jardiance (empagliflozin)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mometasone topical
  • Jardiance (empagliflozin)
    +
    mometasone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + mometasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • morphine
  • Jardiance (empagliflozin)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + morphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • moxifloxacin
  • Jardiance (empagliflozin)
    +
    moxifloxacin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + moxifloxacin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects, fluoroquinolones may alter blood glucose)

  • nadolol
  • Jardiance (empagliflozin)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nadolol

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis (antagonistic effects; additive effects)

  • nalbuphine
  • Jardiance (empagliflozin)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nateglinide
  • Jardiance (empagliflozin)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nateglinide

    monitor glucose; consider decr. nateglinide dose: combo may incr. risk of hypoglycemia (additive effects)

  • nattokinase
  • Jardiance (empagliflozin)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nattokinase

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • naxitamab
  • Jardiance (empagliflozin)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    empagliflozin + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nebivolol
  • Jardiance (empagliflozin)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nebivolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nelfinavir
  • Jardiance (empagliflozin)
    +
    nelfinavir
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nelfinavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • niacin (vitamin B3)
  • Jardiance (empagliflozin)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + niacin (vitamin B3)

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • nicardipine
  • Jardiance (empagliflozin)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nicardipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nifedipine
  • Jardiance (empagliflozin)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nifedipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nimodipine
  • Jardiance (empagliflozin)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nimodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nisoldipine
  • Jardiance (empagliflozin)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nisoldipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitric oxide
  • Jardiance (empagliflozin)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nitric oxide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitrite
  • Jardiance (empagliflozin)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nitroglycerin
  • Jardiance (empagliflozin)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Jardiance (empagliflozin)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • norelgestromin (contraceptive)
  • Jardiance (empagliflozin)
    +
    norelgestromin (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + norelgestromin (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • norepinephrine
  • Jardiance (empagliflozin)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + norepinephrine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • norethindrone (contraceptive)
  • Jardiance (empagliflozin)
    +
    norethindrone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + norethindrone (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • norgestimate (contraceptive)
  • Jardiance (empagliflozin)
    +
    norgestimate (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + norgestimate (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • norgestrel (contraceptive)
  • Jardiance (empagliflozin)
    +
    norgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + norgestrel (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nortriptyline
  • Jardiance (empagliflozin)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    empagliflozin + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • obinutuzumab
  • Jardiance (empagliflozin)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    empagliflozin + obinutuzumab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • octreotide
  • Jardiance (empagliflozin)
    +
    octreotide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + octreotide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ofloxacin
  • Jardiance (empagliflozin)
    +
    ofloxacin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ofloxacin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects, fluoroquinolones may alter blood glucose)

  • olanzapine
  • Jardiance (empagliflozin)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + olanzapine

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • oliceridine
  • Jardiance (empagliflozin)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • olmesartan medoxomil
  • Jardiance (empagliflozin)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + olmesartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • opicapone
  • Jardiance (empagliflozin)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Jardiance (empagliflozin)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    empagliflozin + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxazepam
  • Jardiance (empagliflozin)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    empagliflozin + oxazepam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • oxycodone
  • Jardiance (empagliflozin)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxymorphone
  • Jardiance (empagliflozin)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • paliperidone
  • Jardiance (empagliflozin)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + paliperidone

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • palopegteriparatide
  • Jardiance (empagliflozin)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • paltusotine
  • Jardiance (empagliflozin)
    +
    paltusotine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + paltusotine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pasireotide
  • Jardiance (empagliflozin)
    +
    pasireotide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + pasireotide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pegaspargase
  • Jardiance (empagliflozin)
    +
    pegaspargase
    1 interaction

    Monitor/Modify Tx

    empagliflozin + pegaspargase

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • peginterferon alfa 2a
  • Jardiance (empagliflozin)
    +
    peginterferon alfa 2a
    1 interaction

    Monitor/Modify Tx

    empagliflozin + peginterferon alfa 2a

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (antagonistic effects, additive effects)

  • pentamidine
  • Jardiance (empagliflozin)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + pentamidine

    monitor glucose, BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • pentazocine
  • Jardiance (empagliflozin)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Jardiance (empagliflozin)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    empagliflozin + pentobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • perindopril
  • Jardiance (empagliflozin)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + perindopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • perphenazine
  • Jardiance (empagliflozin)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + perphenazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • phenelzine
  • Jardiance (empagliflozin)
    +
    phenelzine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + phenelzine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Jardiance (empagliflozin)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    empagliflozin + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenoxybenzamine
  • Jardiance (empagliflozin)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + phenoxybenzamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phentolamine
  • Jardiance (empagliflozin)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + phentolamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenylephrine
  • Jardiance (empagliflozin)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + phenylephrine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • phenytoin
  • Jardiance (empagliflozin)
    +
    phenytoin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + phenytoin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pindolol
  • Jardiance (empagliflozin)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + pindolol

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis (antagonistic effects; additive effects)

  • plozasiran
  • Jardiance (empagliflozin)
    +
    plozasiran
    1 interaction

    Monitor/Modify Tx

    empagliflozin + plozasiran

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pramipexole
  • Jardiance (empagliflozin)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    empagliflozin + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prazosin
  • Jardiance (empagliflozin)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prednicarbate topical
  • Jardiance (empagliflozin)
    +
    prednicarbate topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + prednicarbate topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prednisolone
  • Jardiance (empagliflozin)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + prednisolone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prednisone
  • Jardiance (empagliflozin)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + prednisone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • procarbazine
  • Jardiance (empagliflozin)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + procarbazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • prochlorperazine
  • Jardiance (empagliflozin)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • promethazine
  • Jardiance (empagliflozin)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + promethazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • propafenone
  • Jardiance (empagliflozin)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + propafenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • propofol
  • Jardiance (empagliflozin)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + propofol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • propranolol
  • Jardiance (empagliflozin)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + propranolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • protriptyline
  • Jardiance (empagliflozin)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    empagliflozin + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pseudoephedrine
  • Jardiance (empagliflozin)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + pseudoephedrine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • quetiapine
  • Jardiance (empagliflozin)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + quetiapine

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • quinapril
  • Jardiance (empagliflozin)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + quinapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ramipril
  • Jardiance (empagliflozin)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ramipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rasagiline
  • Jardiance (empagliflozin)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    empagliflozin + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • remifentanil
  • Jardiance (empagliflozin)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + remifentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Jardiance (empagliflozin)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    empagliflozin + remimazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • repaglinide
  • Jardiance (empagliflozin)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + repaglinide

    monitor glucose; consider decr. repaglinide dose: combo may incr. risk of hypoglycemia (additive effects)

  • riociguat
  • Jardiance (empagliflozin)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    empagliflozin + riociguat

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • risperidone
  • Jardiance (empagliflozin)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + risperidone

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • ritonavir
  • Jardiance (empagliflozin)
    +
    ritonavir
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ritonavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ropinirole
  • Jardiance (empagliflozin)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ropinirole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ropivacaine
  • Jardiance (empagliflozin)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ropivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rotigotine transdermal
  • Jardiance (empagliflozin)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    empagliflozin + rotigotine transdermal

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • sacrosidase
  • Jardiance (empagliflozin)
    +
    sacrosidase
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sacrosidase

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sacubitril
  • Jardiance (empagliflozin)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Jardiance (empagliflozin)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • segesterone (contraceptive)
  • Jardiance (empagliflozin)
    +
    segesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    empagliflozin + segesterone (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selegiline
  • Jardiance (empagliflozin)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    empagliflozin + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Jardiance (empagliflozin)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    empagliflozin + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sevoflurane
  • Jardiance (empagliflozin)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sevoflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sildenafil
  • Jardiance (empagliflozin)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sildenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • silodosin
  • Jardiance (empagliflozin)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sirolimus albumin-bound
  • Jardiance (empagliflozin)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sirolimus albumin-bound

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium ferric gluconate complex
  • Jardiance (empagliflozin)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • somapacitan
  • Jardiance (empagliflozin)
    +
    somapacitan
    1 interaction

    Monitor/Modify Tx

    empagliflozin + somapacitan

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • somatrogon
  • Jardiance (empagliflozin)
    +
    somatrogon
    1 interaction

    Monitor/Modify Tx

    empagliflozin + somatrogon

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • somatropin
  • Jardiance (empagliflozin)
    +
    somatropin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + somatropin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sotalol
  • Jardiance (empagliflozin)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sotalol

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis (antagonistic effects; additive effects)

  • sparsentan
  • Jardiance (empagliflozin)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Jardiance (empagliflozin)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + spironolactone

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • sucralfate
  • Jardiance (empagliflozin)
    +
    sucralfate
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sucralfate

    monitor glucose w/ sucralfate oral suspension: combo may decr. antidiabetic agent efficacy (antagonistic effects, oral suspension contains sorbitol)

  • sufentanil
  • Jardiance (empagliflozin)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + sufentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • tadalafil
  • Jardiance (empagliflozin)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tadalafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tagraxofusp
  • Jardiance (empagliflozin)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tagraxofusp

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tamsulosin
  • Jardiance (empagliflozin)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Jardiance (empagliflozin)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tapentadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Jardiance (empagliflozin)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + taurine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • telmisartan
  • Jardiance (empagliflozin)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    empagliflozin + telmisartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • temsirolimus
  • Jardiance (empagliflozin)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    empagliflozin + temsirolimus

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • teprotumumab
  • Jardiance (empagliflozin)
    +
    teprotumumab
    1 interaction

    Monitor/Modify Tx

    empagliflozin + teprotumumab

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • terazosin
  • Jardiance (empagliflozin)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tesamorelin
  • Jardiance (empagliflozin)
    +
    tesamorelin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tesamorelin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • thalidomide
  • Jardiance (empagliflozin)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + thalidomide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thioridazine
  • Jardiance (empagliflozin)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thiothixene
  • Jardiance (empagliflozin)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    empagliflozin + thiothixene

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • thyroid
  • Jardiance (empagliflozin)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    empagliflozin + thyroid

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • timolol
  • Jardiance (empagliflozin)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + timolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • timolol ophthalmic
  • Jardiance (empagliflozin)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    empagliflozin + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tipranavir
  • Jardiance (empagliflozin)
    +
    tipranavir
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tipranavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tizanidine
  • Jardiance (empagliflozin)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Jardiance (empagliflozin)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • torsemide
  • Jardiance (empagliflozin)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + torsemide

    monitor BP, glucose, volume status, renal fxn: combo may incr. risk of hypovolemia, renal impairment, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • tramadol
  • Jardiance (empagliflozin)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tramadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Jardiance (empagliflozin)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    empagliflozin + trandolapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tranylcypromine
  • Jardiance (empagliflozin)
    +
    tranylcypromine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + tranylcypromine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trazodone
  • Jardiance (empagliflozin)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + trazodone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Jardiance (empagliflozin)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • triamcinolone
  • Jardiance (empagliflozin)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + triamcinolone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • triamcinolone topical
  • Jardiance (empagliflozin)
    +
    triamcinolone topical
    1 interaction

    Monitor/Modify Tx

    empagliflozin + triamcinolone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • triamterene
  • Jardiance (empagliflozin)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    empagliflozin + triamterene

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • trifluoperazine
  • Jardiance (empagliflozin)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Jardiance (empagliflozin)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    empagliflozin + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • triptorelin
  • Jardiance (empagliflozin)
    +
    triptorelin
    1 interaction

    Monitor/Modify Tx

    empagliflozin + triptorelin

    monitor glucose if prostate cancer use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • valsartan
  • Jardiance (empagliflozin)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    empagliflozin + valsartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vamorolone
  • Jardiance (empagliflozin)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + vamorolone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • vardenafil
  • Jardiance (empagliflozin)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + vardenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • verapamil
  • Jardiance (empagliflozin)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    empagliflozin + verapamil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vorinostat
  • Jardiance (empagliflozin)
    +
    vorinostat
    1 interaction

    Monitor/Modify Tx

    empagliflozin + vorinostat

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • vosoritide
  • Jardiance (empagliflozin)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    empagliflozin + vosoritide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • yohimbe
  • Jardiance (empagliflozin)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    empagliflozin + yohimbe

    monitor BP, especially w/ high yohimbe doses: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ziprasidone
  • Jardiance (empagliflozin)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    empagliflozin + ziprasidone

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@49055a57
  • hypersensitivity reaction
  • angioedema
  • acute kidney injury
  • ketoacidosis
  • UTI, serious
  • hypotension, orthostatic
  • Fournier gangrene
  • lower limb amputation risk

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@50b4c519
  • hypoglycemia (peds patients)
  • UTI
  • genital mycotic infection
  • URI
  • urination incr.
  • dyslipidemia
  • Hct incr.
  • arthralgia
  • nausea
  • Cr incr.

Safety/Monitoring .

Monitoring Parameters
Cr at baseline, then periodically; BP; consider urine ketones if diabetes mellitus type 1 or ketoacidosis risk

Pregnancy/Lactation .

Pregnancy

Clinical Summary

avoid use in 2nd and 3rd trimesters, weigh risk/benefit in 1st trimester; inadequate human data available; risk of reversible adverse effects on renal development and maturation in 2nd and 3rd trimesters based on animal data at 13x MRHD and drug's mechanism of action; no known risk of teratogenicity in 1st trimester based on animal data at up to 128x MRHD

Lactation

Clinical Summary

avoid use while breastfeeding; inadequate human data available, though possible risk of adverse effects on infant renal development and maturation based on drug's mechanism of action; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@4690d976

Metabolism: for empagliflozin: liver; CYP450: none; UGT: 1A3, 1A8, 1A9, 2B7 substrate

Excretion: for empagliflozin: urine 54.4% (50% unchanged), feces 41.2% (majority unchanged); Half-life: 12.4h

Subclass: Diabetes: SGLT2 Inhibitors ; SGLT2 Inhibitors, Cardiovascular ; SGLT2 Inhibitors, Nephrological

Mechanism of Action
for empagliflozin: inhibits sodium-glucose cotransporter 2 (SGLT2), reducing glucose and sodium reabsorption, incr. urinary glucose excretion and sodium delivery to distal tubule; may reduce cardiac preload and afterload, downregulate sympathetic activity, incr. tubuloglomerular feedback, and decr. intraglomerular pressure

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@7dba57cf

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral tablet:

  • 10 mg (30 ea): $569.00
  • 25 mg (30 ea): $569.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form